GlaxoSmithKline wins U.S. approval for new flu vaccine

(Reuters) - U.S. health regulators have approved a new four-strain seasonal influenza vaccine made by GlaxoSmithKline Plc, the company said on Monday.

via Reuters: Health News Read More Here..